Regulatory Update

Weekly Regulatory News

This week in medical device regulatory news, Thailand has introduced new refer and transfer guidelines, Europe released an updated Q&A on IVDR and MDR vigilance terms, and Romania has new rules for Economic Operators.

Published on:
November 20, 2024

THAILAND

Streamlining Medical Device Licensing: New Guidelines for Refer and Transfer Processes

The regulatory authority has introduced updated guidelines (link in Thai) for the Refer and Transfer processes in medical device licensing. These changes aim to enhance transparency and compliance while ensuring public safety. Below are the details of the processes, requirements, and restrictions.

Key Processes

Aspect Refer Transfer
Original Dossier Must be registered in Full CSDT route. Partial registration requires Full CSDT compliance. Must be registered in Full CSDT route. Partial registration requires Full CSDT compliance.
Imports Medical device from both original and new dossiers must be produced by the same physical manufacturer and under the same product owner. Name and address of the physical manufacturer and product owner must remain unchanged.
Local Manufacturers Both medical devices must be registered by the same manufacturing establishment. Manufacturing location must remain the same.
License Status Active Active

Required Documentation

Both processes require a similar set of core documents, with some additional requirements.

Document Refer Transfer
Device labeling Yes Yes
Instructions for Use Yes Yes
Executive Summary Yes Yes
Declaration of Conformity Yes Yes
Letter of Authorization (for importer only) Yes Yes
Letter of Consent for Refer/Transfer of Dossier Yes Yes
Safety Declaration Yes Yes
Declaration of Identically for Refer/Transfer Yes Yes

Prohibited Cases

Certain scenarios are not eligible for Refer or Transfer processes:

Condition Refer Transfer
History of problems or serious incidents Not allowed Not allowed
Concerns about quality, efficacy, or safety Not allowed Not allowed
Methamphetamine test kids in urine (specific cases) Not allowed N/A

Conclusion

These guidelines provide a clear framework for managing brand name changes (Refer) and ownership transitions (Transfer) in the medical device sector. By setting strict requirements and prohibiting cases with safety concerns, the authority ensures regulatory compliance while prioritizing public health.

Manufacturers and stakeholders are encouraged to review the complete guidelines to facilitate smooth licensing transitions.

Learn more about TFDA Thailand Medical Device Registration.

EUROPE

MDCG 2023-3 rev.1: Updated Q&A on Vigilance Terms for MDR and IVDR Compliance

The European Commission’s Directorate-General for Health and Food Safety has released an updated guidance document, MDCG 2023-3 rev.1, providing a comprehensive Q&A on vigilance terms and concepts under Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR). Published on November 11, 2024, this document aims to ensure a unified understanding among competent authorities, economic operators, and other stakeholders for effective implementation of vigilance requirements. The guidance aligns terminology with current regulations and incorporates modifications from earlier Medical Devices Vigilance System guidelines. It applies broadly to medical devices, in vitro diagnostic devices, and accessories, ensuring harmonized compliance across the EU.

Learn more about EU Medical Device Registration.

ROMANIA

Romania Announces Updated Operating Rules for Medical Device Economic Operators

The National Agency of Medicines and Medical Devices in Romania reminds economic operators involved in the import, distribution, installation, and maintenance of medical devices about compliance with OMS no. 566/2020. This regulation sets the framework for approval under Title XX of Law no. 95/2006 on healthcare reform. Operating approvals are valid for three years, provided no significant changes affect the original conditions. Operators must ensure timely renewal to avoid disruptions in their activities. The announcement emphasizes the need for adherence to these regulatory requirements for continued authorization.

Subscribe to newsletter
Subscribe to receive the latest blog posts to your inbox every week.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
Read more

Latest News

Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Contact us